Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Int J Womens Health ; 15: 343-354, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36879792

RESUMO

Purpose: Pregnant women are at greater risk for severe COVID-19 disease and are a priority group for vaccination. Trinidad and Tobago (TTO) introduced COVID-19 vaccination for pregnancy in August 2021, however uptake is presumed to be low. The objective was to determine the COVID-19 vaccine acceptance and uptake rates among pregnant women in TTO and reasons for vaccine hesitancy. Patients and Methods: This was a cross-sectional study on 448 pregnant women conducted at specialized antenatal clinics within the largest Regional Health Authority in TTO, and at one private institution from February 1 to May 6, 2022. Participants completed an adapted WHO questionnaire on reasons for COVID-19 vaccine hesitancy. Logistic regression was used to assess factors affecting vaccination decisions. Results: The vaccine acceptance and uptake rates in pregnancy were 26.4% and 23.6%, respectively. The main reason for vaccine hesitancy was lack of research on the COVID-19 vaccine in pregnancy (70.2%), where 75.5% of women believed the vaccine would harm their babies and 71.2% believed there was not enough data. Women seeking care in the private sector (OR: 5.24, 95% CI: 1.41-19.43) and who had comorbidities (OR: 3.72, 95% CI: 11.57-8.83) were more likely to take the vaccine, while Venezuelan non-nationals (OR: 0.09, 95% CI: 0.01-0.71) were less likely to take the vaccine. Older women (OR: 1.80, 95% CI: 1.12-2.89), women with tertiary education (OR: 1.99, 95% CI: 1.25-3.19), and women seeking care in the private sector (OR: 9.45, 95% CI: 4.36-20.48) were more likely to accept the vaccine. Conclusion: Lack of confidence in the vaccine was the main reason for hesitancy, which may reflect paucity of research, lack of knowledge or misinformation of the vaccine in pregnancy. This highlights the need for more targeted public education campaigns and promotion of the vaccine by health institutions. The knowledge, attitudes, and beliefs of pregnant women obtained from this study can guide the development of vaccination programs in pregnancy.

3.
Int J Gynaecol Obstet ; 139(3): 278-283, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28842988

RESUMO

OBJECTIVE: To evaluate the fetal brain in pregnant women infected with Zika virus in a limited-resource setting. METHODS: In an observational study in Trinidad and Tobago, 100 pregnant women infected with Zika virus who were referred for fetal medicine services provided by a single clinician were enrolled from March 31 to September 2, 2016. Two-dimensional ultrasonography was undertaken. RESULTS: The women were aged 17-41 years (mean 27.5 ± 5.7). Six cases of fetal brain abnormalities consistent with Zika infection were detected before 26 gestational weeks. The gestational period at infection and time of presentation ranged, respectively, from 7+3 to 16+0  weeks and from 23+2 to 25+5  weeks. In all cases, centiles of the biparietal diameter and head circumference decreased progressively over time to below the third centile. The skull contour appeared irregular, owing to collapse or overlap of the fetal skull bones. In four cases, brain anomalies were not obvious on the transabdominal scan but were diagnosed on the transvaginal scan. In a further two cases, brain abnormalities presented after 26 weeks of gestation. CONCLUSION: Overall, 8.0% of women infected with Zika virus had fetuses with brain abnormalities suggestive of Zika congenital syndrome. Six cases were detected before 26 weeks and two cases after 26 weeks.


Assuntos
Encéfalo/diagnóstico por imagem , Doenças Fetais/diagnóstico por imagem , Feto/diagnóstico por imagem , Ultrassonografia Pré-Natal/métodos , Infecção por Zika virus/diagnóstico por imagem , Adolescente , Adulto , Encéfalo/anormalidades , Encéfalo/embriologia , Cefalometria/métodos , Feminino , Doenças Fetais/virologia , Feto/virologia , Idade Gestacional , Humanos , Gravidez , Complicações Infecciosas na Gravidez/diagnóstico por imagem , Complicações Infecciosas na Gravidez/virologia , Trinidad e Tobago , Adulto Jovem , Zika virus , Infecção por Zika virus/embriologia
4.
Artigo em Inglês | MEDLINE | ID: mdl-14752603

RESUMO

Intra-abdominal packing has been used to control massive hemorrhage in many difficult situations. Gynecologists are finding it increasingly useful in controlling persistent hemorrhage in a variety of situations. Recently we found it necessary to use packing for persistent brisk bleeding during 'vaginal hysterectomy' in a patient on aspirin therapy for heart disease. We could find no similar report in the literature and now describe our experience.


Assuntos
Aspirina/efeitos adversos , Bandagens , Histerectomia/efeitos adversos , Inibidores da Agregação Plaquetária/efeitos adversos , Hemorragia Pós-Operatória/terapia , Hemorragia Uterina/terapia , Idoso , Aspirina/uso terapêutico , Feminino , Humanos , Inibidores da Agregação Plaquetária/uso terapêutico , Hemorragia Uterina/etiologia , Vagina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...